We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+2.91%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$136B
AUM Growth
-$2.12B
(-1.5%)
Cap. Flow
-$3.27B
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
35.8%
Holding
339
New
7
Increased
68
Reduced
204
Closed
3
Top Buys
| 1 |
ConocoPhillips
COP
|
+$156M |
| 2 |
AMTM
Amentum Holdings
AMTM
|
+$150M |
| 3 |
PayPal
PYPL
|
+$71.5M |
| 4 |
New Fortress Energy
NFE
|
+$54.1M |
| 5 |
e.l.f. Beauty
ELF
|
+$50.2M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$1.73B |
| 2 |
Wells Fargo
WFC
|
+$293M |
| 3 |
Jacobs Solutions
J
|
+$172M |
| 4 |
KLA
KLAC
|
+$168M |
| 5 |
ExxonMobil
XOM
|
+$165M |
Sector Composition
| 1 | Healthcare | 31.19% |
| 2 | Technology | 30.83% |
| 3 | Industrials | 11.26% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Financials | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
10x Genomics
TXG
$5.3B
| $6.67M | ﹤0.01% |
295,400
+108,600
| +58% | +$2.25M |
|
277
Nurix Therapeutics
NRIX
$2.36B
| $6.52M | ﹤0.01% |
290,000
| – | – |
|
278
EPR Properties
EPR
$4.58B
| $6.34M | ﹤0.01% |
129,260
-2,640
| -2% | -$121K |
|
279
Array Technologies
ARRY
$941M
| $6.02M | ﹤0.01% |
911,600
+8,900
| +1% | +$73.2K |
|
280
Haleon
HLN
$43.4B
| $5.8M | ﹤0.01% |
548,000
| – | – |
|
281
Standard BioTools
LAB
$332M
| $5.72M | ﹤0.01% |
2,962,123
-46,520
| -2% | -$91.1K |
|
282
Zentalis Pharmaceuticals
ZNTL
$329M
| $5.51M | ﹤0.01% |
1,498,030
+265,690
| +22% | +$966K |
|
283
Fortinet
FTNT
$118B
| $5.39M | ﹤0.01% |
69,450
| – | – |
|
284
Deckers Outdoor
DECK
$15B
| $5.11M | ﹤0.01% |
32,064
| – | – |
|
285
JELD-WEN Holding
JELD
$101M
| $4.94M | ﹤0.01% |
312,300
| – | – |
|
|
PRO
286
DELISTED
PROS Holdings
PRO
| $4.72M | ﹤0.01% |
254,980
-38,590
| -13% | -$815K |
|
287
Gildan
GIL
$9.57B
| $4.55M | ﹤0.01% |
96,500
-500
| -0.5% | -$21.1K |
|
288
Immunome
IMNM
$2.58B
| $4.11M | ﹤0.01% |
280,800
+12,000
| +4% | +$171K |
|
289
Rambus
RMBS
$11.2B
| $3.99M | ﹤0.01% |
94,500
-9,100
| -9% | -$441K |
|
|
KYNB
290
Kyntra Bio
KYNB
$29.7M
| $3.96M | ﹤0.01% |
396,449
-149,789
| -27% | -$2.26M |
|
|
LUCK
291
Lucky Strike Entertainment
LUCK
$1B
| $3.84M | ﹤0.01% |
326,900
| – | – |
|
292
Rapid7
RPD
$797M
| $3.82M | ﹤0.01% |
95,830
-2,000
| -2% | -$75.2K |
|
293
Enovis
ENOV
$1.51B
| $3.67M | ﹤0.01% |
85,300
| – | – |
|
294
Ivanhoe Electric
IE
$1.4B
| $3.6M | ﹤0.01% |
425,800
| – | – |
|
295
Shutterstock
SSTK
$303M
| $3.53M | ﹤0.01% |
99,800
| – | – |
|
296
Globus Medical
GMED
$10.8B
| $3.31M | ﹤0.01% |
46,225
-1,300
| -3% | -$91.8K |
|
297
Madison Square Garden
MSGE
$3.55B
| $3.24M | ﹤0.01% |
76,100
| – | – |
|
298
Rivian
RIVN
$25.1B
| $3.21M | ﹤0.01% |
286,180
-26,080
| -8% | -$375K |
|
299
Leslie's
LESL
$52.4M
| $3.09M | ﹤0.01% |
48,840
| – | – |
|
300
OraSure Technologies
OSUR
$296M
| $3.02M | ﹤0.01% |
708,150
-11,400
| -2% | -$49K |
|
Similar funds
